GlassScriptPhysician profile
Anna Costeloe
NPI 1043748072
$4,896.73
in general payments reported to CMS, 2019-2025
10 companies · $222 in 2025
The $222 reported for 2025 was less than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $131 · 2022: $949 · 2023: $96.01 · 2024: $3,498 · 2025: $222.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,996 · Travel and Lodging: $1,820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,996.14 |
| Travel and Lodging | $1,820.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,358.42 | 2023-2024 | Xeomin |
| Stryker Corporation | $404.27 | 2022 | |
| Revance Therapeutics, INC. | $308.71 | 2024-2025 | Daxxify |
| Aerin Medical INC. | $262.32 | 2022 | |
| Intersect Ent, INC. | $249.35 | 2022 | |
| Glaxosmithkline, LLC. | $108.29 | 2021 | |
| Integra Lifesciences Corporation | $100.90 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Galderma Laboratories, L.P. | $48.45 | 2023-2024 | |
| Baxter Healthcare | $33.51 | 2022 | |
| Medtronic, INC. | $22.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Costeloe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.